Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report

INTRODUCTION: sorafenib, a tyrosine-kinase inhibitor, is widely used in the treatment of advanced hepatocellular carcinoma. Drug-related toxicities are generally mild but sorafenib, as other similar agents, may induce elevation of systemic arterial blood pressure levels in relation to an interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Valsuani, Chiara, Siclari, Olimpia, Camerini, Andrea, Canale, Maria Laura, Rondini, Marianna, Donati, Sara, Puccinelli, Paolo, Tartarelli, Gianna, Puccetti, Cheti, Amoroso, Domenico
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803930/
https://www.ncbi.nlm.nih.gov/pubmed/20062650
http://dx.doi.org/10.1186/1757-1626-2-9133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803930/
https://www.ncbi.nlm.nih.gov/pubmed/20062650
http://dx.doi.org/10.1186/1757-1626-2-9133

Ejemplares similares